Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine
Clinical trial NCT00329576 · COMPLETED
Trial details
- NCT number
- NCT00329576
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Enrollment
- 632
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.